Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
767.76
+10.22 (1.35%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eli Lilly Employees
Eli Lilly and Company had 43,000 employees as of December 31, 2023. The number of employees increased by 4,000 or 10.26% compared to the previous year.
Employees
43,000
Change (1Y)
4,000
Growth (1Y)
10.26%
Revenue / Employee
$950,309
Profits / Employee
$194,649
Market Cap
691.32B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
Dec 31, 2021 | 35,000 | 0 | - |
Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
Dec 31, 2016 | 41,975 | 700 | 1.70% |
Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
Dec 31, 2013 | 37,925 | -425 | -1.11% |
Dec 31, 2012 | 38,350 | 270 | 0.71% |
Dec 31, 2011 | 38,080 | -270 | -0.70% |
Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
Dec 31, 2009 | 40,360 | -140 | -0.35% |
Dec 31, 2008 | 40,500 | -100 | -0.25% |
Dec 31, 2007 | 40,600 | -900 | -2.17% |
Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
Dec 31, 1993 | 32,700 | 500 | 1.55% |
Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
LLY News
- 4 hours ago - Zepbound Approved For Sleep Apnea - Forbes
- 5 hours ago - Lilly's weight-loss drug Zepbound wins US FDA approval for sleep apnea - Reuters
- 5 hours ago - FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S. - CNBC
- 5 hours ago - FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity - PRNewsWire
- 9 hours ago - Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now - Seeking Alpha
- 14 hours ago - Indiana Sees $39 Billion Worth of Projects Under Construction, an Industrial Info News Alert - Business Wire
- 15 hours ago - Novo Nordisk Stock Crashes 22% After Disappoitning Obesity Drug Data. Eli Lilly Shares Soar. - Barrons
- 1 day ago - Focus: In weight loss battle, Novo and Lilly face growing offensive from licenced copies - Reuters